Enwei Pharmaceutical Statistics

Total Valuation

SHE:301331 has a market cap or net worth of CNY 2.74 billion. The enterprise value is 2.45 billion.

Market Cap	2.74B
Enterprise Value	2.45B

Important Dates

The last earnings date was Monday, April 27, 2026.

Earnings Date	Apr 27, 2026
Ex-Dividend Date	Jan 8, 2026

Share Statistics

SHE:301331 has 101.08 million shares outstanding. The number of shares has increased by 3.34% in one year.

Current Share Class	101.08M
Shares Outstanding	101.08M
Shares Change (YoY)	+3.34%
Shares Change (QoQ)	-8.20%
Owned by Insiders (%)	1.27%
Owned by Institutions (%)	3.34%
Float	29.07M

Valuation Ratios

The trailing PE ratio is 58.48.

PE Ratio	58.48
Forward PE	n/a
PS Ratio	3.12
PB Ratio	2.52
P/TBV Ratio	3.14
P/FCF Ratio	111.52
P/OCF Ratio	33.65
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.36, with an EV/FCF ratio of 99.85.

EV / Earnings	50.96
EV / Sales	2.79
EV / EBITDA	22.36
EV / EBIT	40.85
EV / FCF	99.85

Financial Position

The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.17.

Current Ratio	2.36
Quick Ratio	1.95
Debt / Equity	0.17
Debt / EBITDA	1.71
Debt / FCF	7.65
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 4.45% and return on invested capital (ROIC) is 6.31%.

Return on Equity (ROE)	4.45%
Return on Assets (ROA)	2.51%
Return on Invested Capital (ROIC)	6.31%
Return on Capital Employed (ROCE)	5.42%
Weighted Average Cost of Capital (WACC)	7.32%
Revenue Per Employee	568,217
Profits Per Employee	31,101
Employee Count	1,548
Asset Turnover	0.59
Inventory Turnover	3.52

Taxes

In the past 12 months, SHE:301331 has paid 11.92 million in taxes.

Income Tax	11.92M
Effective Tax Rate	19.84%

Stock Price Statistics

The stock price has increased by +6.86% in the last 52 weeks. The beta is 0.65, so SHE:301331's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	+6.86%
50-Day Moving Average	27.08
200-Day Moving Average	30.63
Relative Strength Index (RSI)	54.11
Average Volume (20 Days)	1,180,792

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:301331 had revenue of CNY 879.60 million and earned 48.14 million in profits. Earnings per share was 0.46.

Revenue	879.60M
Gross Profit	449.06M
Operating Income	60.06M
Pretax Income	60.06M
Net Income	48.14M
EBITDA	106.98M
EBIT	60.06M
Earnings Per Share (EPS)	0.46

Full Income Statement

Balance Sheet

The company has 474.81 million in cash and 187.90 million in debt, giving a net cash position of 286.91 million or 2.84 per share.

Cash & Cash Equivalents	474.81M
Total Debt	187.90M
Net Cash	286.91M
Net Cash Per Share	2.84
Equity (Book Value)	1.09B
Book Value Per Share	10.55
Working Capital	529.76M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 81.42 million and capital expenditures -56.85 million, giving a free cash flow of 24.57 million.

Operating Cash Flow	81.42M
Capital Expenditures	-56.85M
Depreciation & Amortization	46.92M
Net Borrowing	-10.00M
Free Cash Flow	24.57M
FCF Per Share	0.24

Full Cash Flow Statement

Margins

Gross margin is 51.05%, with operating and profit margins of 6.83% and 5.47%.

Gross Margin	51.05%
Operating Margin	6.83%
Pretax Margin	6.83%
Profit Margin	5.47%
EBITDA Margin	12.16%
EBIT Margin	6.83%
FCF Margin	2.79%

Dividends & Yields

This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 1.30%.

Dividend Per Share	0.35
Dividend Yield	1.30%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	116.67%
Buyback Yield	-3.34%
Shareholder Yield	-2.00%
Earnings Yield	1.76%
FCF Yield	0.90%

Dividend Details

Stock Splits

The last stock split was on May 23, 2024. It was a forward split with a ratio of 1.48.

Last Split Date	May 23, 2024
Split Type	Forward
Split Ratio	1.48

Scores

Altman Z-Score	n/a
Piotroski F-Score	6